Chinese Medicine Association apologize

On December 21, Hongmao pharmaceutical and vice president of Hongmao pharmaceutical won the honorary titles of “star enterprise of fulfilling social responsibility in 2018” and “person award of fulfilling social responsibility in 2018” issued by China Association of traditional Chinese medicine. After the “cross provincial arrest of doctors” was revealed at the beginning of 2018, Hongmao pharmaceutical industry caused public concern and doubt due to this matter.
On December 26, the Chinese Traditional Medicine Association, the organizer standing on the cusp of the storm, apologized for the incident, said it sincerely apologized for lax control, and decided to cancel the recognition of Hongmao pharmaceutical industry and correct the mistakes.
The statement made by the Chinese medicine association seems to have put an end to the event. But what the public wants to know more is: why does Hongmao pharmaceutical industry win the award? Can the evaluation standard be put out for drying?
According to media reports, the relevant director of the China Association of traditional Chinese medicine responded that “Hongmao pharmaceutical wine’s past is the past, the past Hongmao pharmaceutical wine has been turned over through laws and media (regulation) and has taken on social responsibility. We encourage enterprises with a sense of social responsibility, looking at its present and future. Is there any mistake in this matter?” The reporter asked about the “selection criteria” of the award, and the other side said, “we have our criteria, which cannot be disclosed.”
In the era of “everyone has a microphone”, if the evaluation standard of an award can’t be transparent and open, it’s no wrong to be questioned about “operation in the dark box”. In the media reports of the incident, it can be seen that paying for the title of Chinese Medicine Association has also become a “normal operation” of rapidly gaining reputation. It is irresponsible to the society and the public to award Hongmao pharmaceutical “star enterprise of social responsibility”.
Although Hongmao pharmaceutical said that it launched a series of public welfare projects such as “micro filial piety action”, which has achieved good social benefits all over the country.
An award-winning organization should be questioned for any reason, regardless of the deep-seated impact of the enterprise on the society.
The Chinese Medicine Association may as well take out the reasons for the review and expose them to the sun. If there is no mistake, it will be more able to confirm the gold content of the award, more able to convince the public and withstand the test.